Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine

NCT02173899 is registered in ClinicalTrials.gov with Changchun Keygen Biological Products Co., Ltd. as lead sponsor.

NCT NCT02173899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02173899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine
Lead sponsor
Changchun Keygen Biological Products Co., Ltd.
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2014
Completion date
August 31, 2014
Enrollment
716 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

varicella